(NASDAQ: IFRX) Inflarx Nv's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 12.09%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 33.05%.
Inflarx Nv's earnings in 2026 is -$32,837,050.On average, 9 Wall Street analysts forecast IFRX's earnings for 2026 to be -$40,806,260, with the lowest IFRX earnings forecast at -$46,214,674, and the highest IFRX earnings forecast at -$37,136,792. On average, 9 Wall Street analysts forecast IFRX's earnings for 2027 to be -$45,949,411, with the lowest IFRX earnings forecast at -$60,656,760, and the highest IFRX earnings forecast at -$34,042,059.
In 2028, IFRX is forecast to generate -$55,366,241 in earnings, with the lowest earnings forecast at -$98,206,182 and the highest earnings forecast at -$32,494,693.